Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 667,524 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 667,524 | n/a |
| Jun 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 11,824 | $37.3K |
| Mar 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 5,708 | $15.4K |
| Mar 16, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 300,840 | n/a |
| Jan 21, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 1,689 | $4.9K |
| Dec 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 6,517 | $23.9K |
| Oct 20, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 1,248 | $3.3K |
| Sep 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 6,267 | $17.6K |
| Jul 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 1,304 | $1.5K |
| Jun 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 6,422 | $7.4K |